[Influence of drug concentration and blending technology on the content uniformity of mixture for low dose warfarin tablets]. 2016

Jan Elbl, and Jan Muselík, and Aleš Franc, and Jana Mikušová, and Zuzana Dolejší, and David Vetchý

Warfarin is a drug with narrow therapeutic index. Individualization of dose and thorough therapy monitoring is compensated by long time use in praxis and low therapy cost. Considering the low dose usually administered, critical parameter of solid dosage form is its uniformity of content. It has to not only meet the criteria set by pharmacopoeia, but to meet them on statisticall significant level also.This experimental study asseses impact of warfarin concentration and blending time after adition of lubricant on uniformity of content of mixtures and tablets made of them. It concludes, that concentration in 2-2,7% range is optimal and its increase or decrease has a negative effect on uniformity of content. It also confirms 5 minutes of blending after lubricant addition to be adequate, as employing longer blending times leads to mixture overblending.Key words: content uniformity warfarin blending time narrow therapeutic index.

UI MeSH Term Description Entries
D004339 Drug Compounding The preparation, mixing, and assembly of a drug. (From Remington, The Science and Practice of Pharmacy, 19th ed, p1814). Drug Formulation,Drug Preparation,Drug Microencapsulation,Pharmaceutical Formulation,Compounding, Drug,Formulation, Drug,Formulation, Pharmaceutical,Microencapsulation, Drug,Preparation, Drug
D013607 Tablets Solid dosage forms, of varying weight, size, and shape, which may be molded or compressed, and which contain a medicinal substance in pure or diluted form. (Dorland, 28th ed) Tablet
D013678 Technology, Pharmaceutical The application of scientific knowledge or technology to pharmacy and the pharmaceutical industry. It includes methods, techniques, and instrumentation in the manufacture, preparation, compounding, dispensing, packaging, and storing of drugs and other preparations used in diagnostic and determinative procedures, and in the treatment of patients. Technology, Pharmacy,Pharmaceutic Technology,Pharmaceutical Technology,Pharmacy Technology,Technology, Pharmaceutic
D014859 Warfarin An anticoagulant that acts by inhibiting the synthesis of vitamin K-dependent coagulation factors. Warfarin is indicated for the prophylaxis and/or treatment of venous thrombosis and its extension, pulmonary embolism, and atrial fibrillation with embolization. It is also used as an adjunct in the prophylaxis of systemic embolism after myocardial infarction. Warfarin is also used as a rodenticide. 4-Hydroxy-3-(3-oxo-1-phenylbutyl)-2H-1-benzopyran-2-one,Aldocumar,Apo-Warfarin,Coumadin,Coumadine,Gen-Warfarin,Marevan,Tedicumar,Warfant,Warfarin Potassium,Warfarin Sodium,Potassium, Warfarin,Sodium, Warfarin
D054327 Lubricants Compounds that provide LUBRICATION between surfaces in order to reduce FRICTION. Lubricant,Lubricating Agents,Lubrication Agents,Agents, Lubricating,Agents, Lubrication

Related Publications

Jan Elbl, and Jan Muselík, and Aleš Franc, and Jana Mikušová, and Zuzana Dolejší, and David Vetchý
August 2013, Ceska a Slovenska farmacie : casopis Ceske farmaceuticke spolecnosti a Slovenske farmaceuticke spolecnosti,
Jan Elbl, and Jan Muselík, and Aleš Franc, and Jana Mikušová, and Zuzana Dolejší, and David Vetchý
January 1982, Eisei Shikenjo hokoku. Bulletin of National Institute of Hygienic Sciences,
Jan Elbl, and Jan Muselík, and Aleš Franc, and Jana Mikušová, and Zuzana Dolejší, and David Vetchý
January 2009, Pharmaceutical development and technology,
Jan Elbl, and Jan Muselík, and Aleš Franc, and Jana Mikušová, and Zuzana Dolejší, and David Vetchý
January 1988, Bollettino chimico farmaceutico,
Jan Elbl, and Jan Muselík, and Aleš Franc, and Jana Mikušová, and Zuzana Dolejší, and David Vetchý
December 2018, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences,
Jan Elbl, and Jan Muselík, and Aleš Franc, and Jana Mikušová, and Zuzana Dolejší, and David Vetchý
November 2007, Bosnian journal of basic medical sciences,
Jan Elbl, and Jan Muselík, and Aleš Franc, and Jana Mikušová, and Zuzana Dolejší, and David Vetchý
January 2013, Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society,
Jan Elbl, and Jan Muselík, and Aleš Franc, and Jana Mikušová, and Zuzana Dolejší, and David Vetchý
April 1981, The Journal of pharmacy and pharmacology,
Jan Elbl, and Jan Muselík, and Aleš Franc, and Jana Mikušová, and Zuzana Dolejší, and David Vetchý
June 2006, Applied spectroscopy,
Jan Elbl, and Jan Muselík, and Aleš Franc, and Jana Mikušová, and Zuzana Dolejší, and David Vetchý
March 1971, Journal of pharmaceutical sciences,
Copied contents to your clipboard!